Genomatica has signed a multi-year licensing agreement with TeselaGen Biotechnology that allows it to use the company's automated DNA cloning software for its microbial strain engineering projects.

Specifically, Genomatica intends to use the software to develop proprietary organisms that it will license to customers who will use them to produce chemicals from renewable feedstocks. In addition, the partnership is an opportunity for TeselaGen to further develop its software for industrial use, according to Michael Fero, TeselaGen's co-founder and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.